COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Clinical trial NCT05236491 · UNKNOWN

Trial details

NCT number: NCT05236491
Sponsor: Paul R Fortin
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis Autoimmune Rheumatologic Disease Systemic Lupus Erythematosus Systemic Vasculitis Systemic Sclerosis Scleroderma Undifferentiated Connective Tissue Diseases Overlap Connective Tissue Disease Immunosuppression

Start date: 2022-03-09
Primary completion: 2023-06-01
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.